과제정보
This work was supported by grant of Korea of Health & Welfare, Republic of Korea (Project No: 20-11-0-090-091-3000-3033-320).
참고문헌
- Fisher B, Costantino JP, Wickerham DL, Redmond CK, Kavanah M, Cronin WM, et al., Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study. Journal of the National Cancer Institute, 1998;90(18):1371-1388. https://doi.org/10.1093/jnci/90.18.1371
- Lerner HJ, Band PR, Israel L, Leung BS, Phase II study of tamoxifen: report of 74 patients with stage IV breast cancer. Cancer treatment reports, 1976;60(10):1431-1435.
- Zeneca Pharmaceuticals, Nolvadex (tamoxifen citrate) prescribing information. 1998.
- Braems G, Denys H, De Wever O, Cocquyt V, Van den Broecke R, Use of tamoxifen before and during pregnancy. The oncologist, 2011;16(11):1547-1551. https://doi.org/10.1634/theoncologist.2011-0121
- Karn A, Jha AK, Shrestha S, Acharya B, Poudel S, Bhandari RB, Tamoxifen for breast cancer. JNMA; journal of the Nepal Medical Association, 2010;49(177):62-67.
- Notley LM, Crewe KH, Taylor PJ, Lennard MS, Gillam EM, Characterization of the human cytochrome P450 forms involved in metabolism of tamoxifen to its α-hydroxy and α,4-dihydroxy derivatives. Chemical research in toxicology, 2005;18(10):1611-1618. https://doi.org/10.1021/tx050140s
- Lien EA, Anker G, Lonning PE, Solheim E, Ueland PM, Decreased serum concentrations of tamoxifen and its metabolites induced by aminoglutethimide. Cancer research, 1990;50(18):5851-5857.
- Ritchie LD, Grant SM, Tamoxifen-warfarin interaction: the Aberdeen hospitals drug file. BMJ (Clinical research ed.), 1989;298(6682):1253. https://doi.org/10.1136/bmj.298.6682.1253
- Lamberts SW, Verleun T, Hofland L, Oosterom R, Differences in the interaction between dopamine and estradiol on prolactin release by cultured normal and tumorous human pituitary cells. The Journal of clinical endocrinology and metabolism, 1986;63(6):1342-1347. https://doi.org/10.1210/jcem-63-6-1342
- Dowsett M, Pfister C, Johnston SR, Miles DW, Houston SJ, Verbeek JA, et al., Impact of tamoxifen on the pharmacokinetics and endocrine effects of the aromatase inhibitor letrozole in postmenopausal women with breast cancer. Clinical cancer research : an official journal of the American Association for Cancer Research, 1999;5(9):2338-2343.
- Reid AD, Horobin JM, Newman EL, Preece PE, Tamoxifen metabolism is altered by simultaneous administration of medroxyprogesterone acetate in breast cancer patients. Breast cancer research and treatment, 1992;22(2):153-156. https://doi.org/10.1007/bf01833345
- Dehal SS, Brodie AM, Kupfer D, The aromatase inactivator 4-hydroxyandrostenedione (4-OH-A) inhibits tamoxifen metabolism by rat hepatic cytochrome P-450 3A: potential for drug-drug interaction of tamoxifen and 4-OH-A in combined anti-breast cancer therapy. Drug metabolism and disposition: the biological fate of chemicals, 1999;27(3):389-394.
- West CM, Reeves SJ, Brough W, Additive interaction between tamoxifen and rifampicin in human biliary tract carcinoma cells. Cancer letters, 1990;55(2):159-163. https://doi.org/10.1016/0304-3835(90)90027-U
- Williams JA, Ring BJ, Cantrell VE, Jones DR, Eckstein J, Ruterbories K, et al., Comparative metabolic capabilities of CYP3A4, CYP3A5, and CYP3A7. Drug metabolism and disposition: the biological fate of chemicals, 2002;30(8):883-891. https://doi.org/10.1124/dmd.30.8.883
- Terauchi M, Hiramitsu S, Akiyoshi M, Owa Y, Kato K, Obayashi S, et al., Effects of three Kampo formulae: Tokishakuyakusan (TJ-23), Kamishoyosan (TJ-24), and Keishibukuryogan (TJ-25) on Japanese peri- and postmenopausal women with sleep disturbances. Archives of gynecology and obstetrics, 2011;284(4):913-921. https://doi.org/10.1007/s00404-010-1779-4
- Hidaka T, Yonezawa R, Saito S, Kami-shoyo-san, Kampo (Japanese traditional medicine), is effective for climacteric syndrome, especially in hormone-replacement-therapy-resistant patients who strongly complain of psychological symptoms. The journal of obstetrics and gynaecology research, 2013; 39(1):223-228. https://doi.org/10.1111/j.1447-0756.2012.01936.x
- Kimura Y, Takamatsu K, Fujii A, Suzuki M, Chikada N, Tanada R, et al., Kampo therapy for premenstrual syndrome: efficacy of Kamishoyosan quantified using the second derivative of the fingertip photoplethysmogram. The journal of obstetrics and gynaecology research, 2007;33(3):325-332. https://doi.org/10.1111/j.1447-0756.2007.00531.x
- Qu Y, Gan HQ, Mei QB, Liu L, Study on the effect of Jia-Wei-Xiao-Yao-San decoction on patients with functional dyspepsia. Phytotherapy research : PTR, 2010;24(2): 245-248. https://doi.org/10.1002/ptr.2920
- Ishikawa T, Funahashi T, Kudo J, Effectiveness of the Kampo kami-shoyo-san (TJ-24) for tremor of antipsychotic-induced parkinsonism. Psychiatry and clinical neurosciences, 2000;54(5):579-582. https://doi.org/10.1046/j.1440-1819.2000.00756.x
- Kim JI, Ku SK, Lee YJ, Effect of the Single Oral Combination Treatment of Tamoxifen with Gamisoyo-san on the Pharmacokinetics Profiles of Tamoxifen. J Physiol & Pathol Korean Med, 2020;34(4):201-208. https://doi.org/10.15188/kjopp.2020.08.34.4.201
- Gibaldi M, Perrier D, Pharmacokinetics. 2nd ed. Taylor & Francis. 1982.
- Chiou WL, Critical evaluation of the potential error in pharmacokinetic studies of using the linear trapezoidal rule method for the calculation of the area under the plasma level-time curve. Journal of pharmacokinetics and biopharmaceutics, 1978;6(6):539-546. https://doi.org/10.1007/BF01062108
- Adam HK, Patterson JS, Kemp JV, Studies on the metabolism and pharmacokinetics of tamoxifen in normal volunteers. Cancer treatment reports, 1980;64(6-7):761-764.
- Murphy C, Fotsis T, Pantzar P, Adlercreutz H, Martin F, Analysis of tamoxifen and its metabolites in human plasma by gas chromatography-mass spectrometry (GC-MS) using selected ion monitoring (SIM). Journal of steroid biochemistry, 1987;26(5):547-555. https://doi.org/10.1016/0022-4731(87)90006-9
- Jordan VC, Metabolites of tamoxifen in animals and man: identification, pharmacology, and significance. Breast cancer research and treatment, 1982;2(2):123-138. https://doi.org/10.1007/BF01806449
- Sun D, Sharma AK, Dellinger RW, Blevins -Primeau AS, Balliet RM, Chen G, et al., Glucuronidation of active tamoxifen metabolites by the human UDP glucuronosyltransferases. Drug metabolism and disposition: the biological fate of chemicals, 2007;35(11):2006-2014. https://doi.org/10.1124/dmd.107.017145
- AstraZeneca Pharmaceuticals, Nolvadex (tamoxifen citrate) prescribing information. 2003.
- Vehmanen L, Elomaa I, Blomqvist C, Saarto T, Tamoxifen treatment after adjuvant chemotherapy has opposite effects on bone mineral density in premenopausal patients depending on menstrual status. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2006;24(4):675-680. https://doi.org/10.1200/JCO.2005.02.3515
- Grilli S, Tamoxifen (TAM): the dispute goes on. Annali dell'Istituto superiore di sanita, 2006;42(2):170-173.
- Decensi A, Maisonneuve P, Rotmensz N, Bettega D, Costa A, Sacchini V, et al., Effect of tamoxifen on venous thromboembolic events in a breast cancer prevention trial. Circulation, 2005;111(5):650-656. https://doi.org/10.1161/01.CIR.0000154545.84124.AC
- Osman KA, Osman MM, Ahmed MH, Tamoxifen-induced non-alcoholic steatohepatitis: where are we now and where are we going? Expert opinion on drug safety, 2007;6(1):1-4. https://doi.org/10.1517/14740338.6.1.1
- Paganini-Hill A, Clark LJ, Preliminary assessment of cognitive function in breast cancer patients treated with tamoxifen. Breast cancer research and treatment, 2000;64(2):165-176. https://doi.org/10.1023/A:1006426132338
- Eberling JL, Wu C, Tong-Turnbeaugh R, Jagust WJ, Estrogen- and tamoxifen-associated effects on brain structure and function. NeuroImage, 2004;21(1):364-371. https://doi.org/10.1016/j.neuroimage.2003.08.037
- Cella D, Fallowfield L, Barker P, Cuzick J, Locker G, Howell A, et al., Quality of life of postmenopausal women in the ATAC ("Arimidex", tamoxifen, alone or in combination) trial after completion of 5 years' adjuvant treatment for early breast cancer. Breast cancer research and treatment, 2006;100(3):273-284. https://doi.org/10.1007/s10549-006-9260-6
- Karimian E, Chagin AS, Gjerde J, Heino T, Lien EA, Ohlsson C, et al., Tamoxifen impairs both longitudinal and cortical bone growth in young male rats. Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research, 2008;23(8):1267-1277. https://doi.org/10.1359/jbmr.080319
- Nalbandian G, Paharkova-Vatchkova V, Mao A, Nale S, Kovats S, The selective estrogen receptor modulators, tamoxifen and raloxifene, impair dendritic cell differentiation and activation. Journal of immunology (Baltimore, Md. : 1950), 2005;175(4):2666-2675. https://doi.org/10.4049/jimmunol.175.4.2666
- Rousset-Jablonski C, Thalabard JC, Gompel A, Tamoxifen contraindicated in women with hereditary angioedema? Annals of oncology : official journal of the European Society for Medical Oncology / ESMO, 2009;20(7):1281-1282. https://doi.org/10.1093/annonc/mdp295
- Kwak MA, Park SJ, Park SH, Lee YJ, Ku SK, Effect of Jaeumkanghwatang (JEKHT), a Polyherbal Formula on the Pharmacokinetics Profiles of Tamoxifen in Male SD Rats (1) - Single Oral Combination Treatment of Tamoxifen 50 mg/kg with JEKHT 100 mg/kg within 5 min -. J Korean Med, 2016;37(2):1-11. https://doi.org/10.13048/jkm.16016
- Park SJ, Kwak MA, Park SH, Lee YJ, Ku SK, Effect of Jaeumkanghwatang (JEKHT), a Polyherbal Formula on the Pharmacokinetics Profiles of Tamoxifen in Male SD Rats (2) - Oral Combination Treatment of Tamoxifen 50 mg/kg with JEKHT 100 mg/kg on JEKHT 6-day Repeated Pretreated Rats with 8-day Repeated. J Soc Prev Korean Med, 2016;20(2):97-109.